You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    High-Dose Methotrexate Clearance in Diffuse Large B-Cell

    Recruiting
    • Central Nervous System Lymphoma
    • Diffuse Large B-Cell Lymphoma
    • Non-Interventional Study
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 8, 2023

    Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • GEN3017
    • (no location specified)
    Aug 25, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Communication Training Intervention for Large B-Cell Lymphoma

    Recruiting
    • Lymphoma, B-Cell
    • +5 more
    • Hematolo-GIST Training
    • Participants Appointment
    • New York, New York
    • +2 more
    Jul 3, 2023

    Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

    Not yet recruiting
    • Lymphoma, B-Cell
    • +7 more
    • Adaptive Bridging Radiation Therapy (ABRT)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 16, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

    Withdrawn
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • (no location specified)
    Jun 28, 2023

    Elastography and Treatment of Lymphoma

    Not yet recruiting
    • Elastography
    • Lymphoma
      • (no location specified)
      Jul 23, 2023

      Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

      Not yet recruiting
      • Primary Ocular Adnexal MALT Lymphoma
      • (no location specified)
      Sep 26, 2023

      Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Diffuse Large B Cell Lymphoma
      • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
      • Tianjin, Tianjin, China
        Tianjin Cancer Hospital
      Nov 19, 2023

      Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

      Recruiting
      • Burkitt Lymphoma
      • +2 more
      • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
      • Zhuhai, Guangdong, China
        The Fifth Affiliated Hospital of Sun Yat-sen University
      Sep 25, 2023

      Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

      Recruiting
      • Diffuse Large B-cell Lymphoma Recurrent
      • Diffuse Large B Cell Lymphoma Refractory
      • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Oct 12, 2023

      ASCT Versus Chemotherapy as First-Line Consolidation Therapy

      Completed
      • T-cell Lymphoma Adults
      • consolidation with ASCT
      • (no location specified)
      Nov 25, 2023

      Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

      Not yet recruiting
      • Follicular Lymphoma
      • New York, New York
        Weill Cornell Medicine/NewYork-Presbyterian Hospital
      Aug 8, 2023

      Patient Perspectives in Mantle Cell Lymphoma Clinical Research

      Not yet recruiting
      • Mantle Cell Lymphoma
        • San Francisco, California
          Power Life Sciences
        Sep 15, 2023

        Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

        Recruiting
        • Peripheral T Cell Lymphoma
        • +2 more
        • Chidamide combined with Duvillisib
        • Xiamen, Fujian, China
          The First Affiliated Hosptial of Xiamen University
        Nov 28, 2023

        Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

        Not yet recruiting
        • Relapsed Non-Hodgkin Lymphoma
        • +6 more
        • (no location specified)
        Apr 12, 2023

        Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
        • (no location specified)
        Sep 5, 2023

        Lymphoma Trial (Fatigue Reduction Diet, General Health Curriculum)

        Not yet recruiting
        • Lymphoma
        • Fatigue Reduction Diet
        • General Health Curriculum
        • (no location specified)
        Sep 14, 2023

        Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma Trial (intensity-modulated radiotherapy (IMRT))

        Not yet recruiting
        • Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
        • intensity-modulated radiotherapy (IMRT)
        • (no location specified)
        Jun 4, 2023